PERCEPTIVE ADVISORS LLC
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 99% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
91 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $5,100,117,995 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RLAY | Relay Therapeutics, Inc. | +7,847,896 | 9,751,141 | $97,023,852 | |
| SABS | SAB Biotherapeutics, Inc. | +5,628,533 | 6,431,743 | $24,633,575 | |
| BCRX | Biocryst Pharmaceuticals Inc | +4,271,504 | 7,434,033 | $70,771,994 | |
| CNTA | Centessa Pharmaceuticals plc | +2,341,269 | 5,258,903 | $208,883,627 | |
| AVR | Anteris Technologies Global Corp. | +1,750,000 | 3,425,476 | $19,011,391 | |
| CRVS | Corvus Pharmaceuticals, Inc. | +1,600,000 | 2,292,441 | $33,538,411 | |
| DYN | Dyne Therapeutics, Inc. | +1,189,895 | 4,668,839 | $84,646,051 | |
| TENX | Tenax Therapeutics, Inc. | +1,008,640 | 1,447,782 | $23,150,034 | |
| SYRE | Spyre Therapeutics, Inc. | +714,000 | 3,783,225 | $190,825,869 | |
| ASND | Ascendis Pharma A/S | +450,000 | 1,531,421 | $350,281,925 | |
| XFOR | X4 Pharmaceuticals, Inc | +423,196 | 6,737,648 | $27,826,486 | |
| CTMX | CytomX Therapeutics, Inc. | +418,639 | 10,098,824 | $47,464,472 | |
| ROIV | Roivant Sciences Ltd. | +300,000 | 8,285,461 | $229,507,269 | |
| TNGX | Tango Therapeutics, Inc. | +295,118 | 808,153 | $16,906,560 | |
| ZYME | Zymeworks Inc. | +248,228 | 3,510,078 | $87,892,353 | |
| BBNX | Beta Bionics, Inc. | +240,000 | 842,944 | $8,446,298 | |
| ANRO | Alto Neuroscience, Inc. | +225,500 | 2,009,893 | $45,182,394 | |
| NRIX | Nurix Therapeutics, Inc. | +155,000 | 3,710,877 | $57,518,593 | |
| GH | Guardant Health, Inc. | +140,000 | 300,000 | $27,711,000 | |
| SLDB | Solid Biosciences Inc. | +73,107 | 11,906,646 | $85,727,851 | |
| PRAX | Praxis Precision Medicines, Inc. | +40,000 | 2,035,986 | $655,974,329 | |
| BLLN | BillionToOne, Inc. | +19,000 | 91,812 | $7,247,639 | |
| AXSM | Axsome Therapeutics, Inc. | +1,050 | 149,950 | $25,344,549 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PALI | Palisade Bio, Inc. | −3,121,851 | 8,928,149 | $15,624,260 | |
| IKT | Inhibikase Therapeutics, Inc. | −3,106,568 | 2,315,000 | $3,889,200 | |
| IRD | Opus Genetics, Inc. | −2,489,158 | 1,835,842 | $8,353,081 | |
| VRDN | Viridian Therapeutics, Inc.\DE | −1,871,874 | 1,170,829 | $22,901,415 | |
| OMDA | Omada Health, Inc. | −1,610,000 | 786,330 | $9,884,168 | |
| IVVD | Invivyd, Inc. | −925,863 | 20,859,303 | $27,117,093 | |
| APGE | Apogee Therapeutics, Inc. | −790,267 | 1,540,384 | $129,654,121 | |
| SION | Sionna Therapeutics, Inc. | −520,659 | 658,439 | $26,396,819 | |
| ADMA | Adma Biologics, Inc. | −416,235 | 467,233 | $4,209,769 | |
| IMVT | Immunovant, Inc. | −397,507 | 1,597,383 | $39,678,993 | |
| NBIX | Neurocrine Biosciences Inc | −266,000 | 65,050 | $8,569,687 | |
| BLTE | Belite Bio, Inc | −262,260 | 151,979 | $24,231,531 | |
| CBIO | Crescent Biopharma, Inc. | −246,744 | 206,942 | $3,801,524 | |
| CTNM | Contineum Therapeutics, Inc. | −209,000 | 1,255,592 | $16,398,031 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | −172,596 | 2,373,795 | $206,448,951 | |
| CPIX | Cumberland Pharmaceuticals Inc | −144,109 | 196,978 | $640,178 | |
| TVTX | Travere Therapeutics, Inc. | −135,629 | 4,142,551 | $123,075,190 | |
| ABVX | Abivax S.A. | −129,459 | 328,884 | $36,621,233 | |
| PTGX | Protagonist Therapeutics, Inc | −119,546 | 1,230,879 | $129,734,646 | |
| OBIO | Orchestra BioMed Holdings, Inc. | −89,350 | 5,037,906 | $21,411,100 | |
| AXGN | Axogen, Inc. | −86,828 | 697,312 | $23,101,946 | |
| AORT | Artivion, Inc. | −85,000 | 1,637,290 | $59,957,559 | |
| NUVL | Nuvalent, Inc. | −84,600 | 1,580,505 | $161,922,737 | |
| ORKA | Oruka Therapeutics, Inc. | −81,000 | 1,395,501 | $68,449,324 | |
| DRUG | Bright Minds Biosciences Inc. | −71,746 | 377,544 | $27,549,385 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MRNA | Moderna, Inc. | 1,000,000 | $50,800,000 | |
| IONS | Ionis Pharmaceuticals Inc | 504,000 | $37,845,360 | |
| DAWN | Day One Biopharmaceuticals, Inc. | 1,755,799 | $37,644,330 | |
| DMRA | Damora Therapeutics, Inc. | 1,223,000 | $31,675,700 | |
| RVMD | Revolution Medicines, Inc. | 258,600 | $25,148,850 | |
| DBVT | DBV Technologies S.A. | 964,391 | $20,146,127 | |
| STRO | Sutro Biopharma, Inc. | 715,307 | $17,818,297 | |
| EVMN | Evommune, Inc. | 448,350 | $10,307,566 | |
| PHAT | Phathom Pharmaceuticals, Inc. | 925,000 | $10,276,750 | |
| NMRA | Neumora Therapeutics, Inc. | 5,104,097 | $9,952,989 | |
| TWST | Twist Bioscience Corp | 150,000 | $7,128,000 | |
| SRZN | Surrozen, Inc./DE | 229,393 | $6,682,218 | |
| AGMB | Agomab Therapeutics NV | 600,000 | $6,294,000 | |
| EOLS | Evolus, Inc. | 1,286,862 | $5,289,002 | |
| OCUL | Ocular Therapeutix, Inc | 500,000 | $4,235,000 | |
| APLS | Apellis Pharmaceuticals, Inc. | 80,956 | $3,256,859 | |
| EDSA | Edesa Biotech, Inc. | 563,239 | $2,945,739 | |
| CORT | Corcept Therapeutics Inc | 50,000 | $2,015,500 | |
| ADPT | Adaptive Biotechnologies Corp | 152,500 | $529,175 | |
| XGN | Exagen Inc. | 114,893 | $344,679 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| EXAS | EXACT SCIENCES CORP | 1,200,487 | $121,921,459 | |
| ACLX | Arcellx, Inc. | 1,466,071 | $95,587,829 | |
| BSX | Boston Scientific Corp | 979,000 | $93,347,650 | |
| FOLD | AMICUS THERAPEUTICS, INC. | 6,370,851 | $90,720,918 | |
| DHR | Danaher Corp /De/ | 200,000 | $45,784,000 | |
| IRON | Disc Medicine, Inc. | 450,743 | $35,793,501 | |
| PEN | Penumbra Inc | 110,529 | $34,364,571 | |
| CAI | Caris Life Sciences, Inc. | 1,136,206 | $30,654,837 | |
| PVLA | Palvella Therapeutics, Inc. | 266,287 | $27,872,260 | |
| KOD | Kodiak Sciences Inc. | 848,900 | $23,735,244 | |
| BIIB | Biogen Inc. | 124,000 | $21,822,760 | |
| ALDX | Aldeyra Therapeutics, Inc. | 4,185,632 | $21,681,573 | |
| MIRM | Mirum Pharmaceuticals, Inc. | 259,545 | $20,501,459 | |
| GRAL | GRAIL, Inc. | 237,342 | $20,314,101 | |
| CVS | CVS HEALTH Corp | 220,000 | $17,459,200 | |
| GKOS | GLAUKOS Corp | 140,000 | $15,807,400 | |
| DXCM | Dexcom Inc | 225,758 | $14,983,558 | |
| SVRA | Savara Inc | 2,400,000 | $14,472,000 | |
| SEPN | Septerna, Inc. | 433,160 | $12,076,500 | |
| GOSS | Gossamer Bio, Inc. | 3,139,669 | $9,732,973 | |
| MPLT | MapLight Therapeutics, Inc. | 550,000 | $9,660,750 | |
| XENE | Xenon Pharmaceuticals Inc. | 200,791 | $8,999,452 | |
| KMTS | Kestra Medical Technologies, Ltd. | 285,000 | $7,558,200 | |
| CAPR | Capricor Therapeutics, Inc. | 242,100 | $6,987,006 | |
| BHVN | Biohaven Ltd. | 500,000 | $5,645,000 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 2,035,986 | $655,974,329 | 12.86% | |
| CELC |
Celcuity Inc.
Healthcare
|
Reduced | 3,127,200 | $356,938,608 | 7.00% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 1,531,421 | $350,281,925 | 6.87% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Added | 8,285,461 | $229,507,269 | 4.50% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Added | 5,258,903 | $208,883,627 | 4.10% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Reduced | 2,373,795 | $206,448,951 | 4.05% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Added | 3,783,225 | $190,825,869 | 3.74% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Reduced | 1,580,505 | $161,922,737 | 3.17% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 4,423,974 | $139,355,181 | 2.73% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Reduced | 1,230,879 | $129,734,646 | 2.54% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Reduced | 1,540,384 | $129,654,121 | 2.54% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Reduced | 4,142,551 | $123,075,190 | 2.41% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Held | 8,284,882 | $115,159,859 | 2.26% | |
| IMTX |
Immatics N.V.
Healthcare
|
Held | 10,383,456 | $102,173,207 | 2.00% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Added | 9,751,141 | $97,023,852 | 1.90% | |
| INBX |
Inhibrx Biosciences, Inc.
Healthcare
|
Reduced | 1,442,707 | $96,993,191 | 1.90% | |
| MGTX |
MeiraGTx Holdings plc
Healthcare
|
Held | 10,326,103 | $89,424,051 | 1.75% | |
| ZYME |
Zymeworks Inc.
Healthcare
|
Added | 3,510,078 | $87,892,353 | 1.72% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Added | 11,906,646 | $85,727,851 | 1.68% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 4,668,839 | $84,646,051 | 1.66% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Added | 7,434,033 | $70,771,994 | 1.39% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Reduced | 1,395,501 | $68,449,324 | 1.34% | |
| AORT |
Artivion, Inc.
Healthcare
|
Reduced | 1,637,290 | $59,957,559 | 1.18% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Added | 3,710,877 | $57,518,593 | 1.13% | |
| MRNA |
Moderna, Inc.
PUT
Healthcare
|
NEW | 1,000,000 | $50,800,000 | 1.00% | |
| NAUT |
Nautilus Biotechnology, Inc.
Healthcare
|
Held | 12,594,211 | $48,865,538 | 0.96% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Added | 10,098,824 | $47,464,472 | 0.93% | |
| ANRO |
Alto Neuroscience, Inc.
Healthcare
|
Added | 2,009,893 | $45,182,394 | 0.89% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Reduced | 5,827,506 | $39,685,315 | 0.78% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Reduced | 1,597,383 | $39,678,993 | 0.78% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 85,419 | $39,377,304 | 0.77% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
NEW | 504,000 | $37,845,360 | 0.74% | |
| DAWN |
Day One Biopharmaceuticals, Inc.
Healthcare
|
NEW | 1,755,799 | $37,644,330 | 0.74% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 328,884 | $36,621,233 | 0.72% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
Added | 2,292,441 | $33,538,411 | 0.66% | |
| RGEN |
Repligen Corp
Healthcare
|
Reduced | 280,541 | $33,053,340 | 0.65% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
Held | 170,000 | $32,138,500 | 0.63% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
NEW | 1,223,000 | $31,675,700 | 0.62% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Added | 6,737,648 | $27,826,486 | 0.55% | |
| GH |
Guardant Health, Inc.
Healthcare
|
Added | 300,000 | $27,711,000 | 0.54% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Reduced | 377,544 | $27,549,385 | 0.54% | |
| IVVD |
Invivyd, Inc.
Healthcare
|
Reduced | 20,859,303 | $27,117,093 | 0.53% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Reduced | 658,439 | $26,396,819 | 0.52% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 149,950 | $25,344,549 | 0.50% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
NEW | 258,600 | $25,148,850 | 0.49% | |
| SABS |
SAB Biotherapeutics, Inc.
Healthcare
|
Added | 6,431,743 | $24,633,575 | 0.48% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
Reduced | 151,979 | $24,231,531 | 0.48% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Added | 1,447,782 | $23,150,034 | 0.45% | |
| AXGN |
Axogen, Inc.
Healthcare
|
Reduced | 697,312 | $23,101,946 | 0.45% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Reduced | 1,170,829 | $22,901,415 | 0.45% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.